France
HypnoVR, founded in 2016, is an innovative player in the Health Care, Medical Devices, and VR/AR sectors, headquartered in France. The company’s slogan, "Treating pain and anxiety differently," encapsulates its core mission of revolutionizing patient care.
With the unique combination of medical hypnosis and virtual reality, HypnoVR distinguishes itself with a track record of efficacy demonstrated through 15 clinical studies, including reducing postoperative length of stay by a factor of 3.57 and morphine consumption by 45%. These statistics highlight its potential to significantly enhance patient outcomes.
Backed by a €4.50M Series A investment received on 07 December 2021 from investors such as Bpifrance, Banque des Territoires, and Theodorus III, HypnoVR aligns with hygiene standards and integrates seamlessly into healthcare settings with both fixed and mobile equipment, offering health professionals an efficient therapeutic tool.
Their market penetration includes collaborations with major groups like UniHA and Vivalto Santé, positioning HypnoVR as a compelling opportunity for investors seeking to impact the future of pain management.
